Kriya Therapeutics, Inc.
4 private offerings reported to the SEC on Form D since 2016, $870.3M sold in all. Biotech, North Carolina.
- Form D offerings: 4
- Reported sold: $870.3M
- Newest: Aug 15, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Aug 15, 2025 | — | $320.8M | $320.8M | Kriya Therapeutics, Inc.Biotech · North Carolina | Sep 10, 2025 | 0001811209-25-000002 |
| May 24, 2022 | — | $361.8M | $432.0M | Kriya Therapeutics, Inc.Biotech · California | Jul 27, 2023 | 0001811209-22-000001 |
| Jul 14, 2021 | — | $100.0M | $100.0M | Kriya Therapeutics, Inc.Biotech · California | Not amended | 0001811209-21-000002 |
| May 19, 2020 | — | $87.6M | $87.6M | Kriya Therapeutics, Inc.Biotech · California | Aug 18, 2020 | 0001811209-20-000001 |
- Business address
- Morrisville, NC
- Incorporated in
- Delaware
- All SEC filings
- CIK 1811209 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR